Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep750 | Calcium and Bone | ECE2024

Can tenascin - X be a marker of bone turnover in patients with Ehlers-Danlos syndrome?

Żuk - Łapan Aleksandra , Emilia Babula , Iga Poprawa , Jakub Podstawka , Latocha Julia , Szymańska Zuzanna , Jan Domański , Małgorzata Zagozda , Juliusz Wilk , Tomasz Korcz , Małgorzata Cicha-Brzezińska , Kaluza Bernadetta , Franek Edward

Background: The alterations in collagen synthesis and connective tissue structure that occur in Ehlers–Danlos syndrome translate to an increased risk of bone mass loss and development of osteopenia and osteoporosis, which may be evaluated with bone turnover biomarkers. Some subtypes of Ehlers–Danlos syndrome are associated with structural alterations in the extracellular matrix glycoprotein tenascin-X. The purpose of this study was to assess the relationship between ...

ea0099ep420 | Adrenal and Cardiovascular Endocrinology | ECE2024

Does tenascin-X correlate with adrenal dysfunction in patients with Ehlers–Danlos syndrome?

Jan Domański , Emilia Babula , Iga Poprawa , Aleksandra Żuk-Łapan , Jakub Podstawka , Latocha Julia , Szymańska Zuzanna , Małgorzata Zagozda , Juliusz Wilk , Tomasz Korcz , Małgorzata Cicha-Brzezińska , Anna Siejka , Bartosz Mruk , Jerzy Walecki , Kaluza Bernadetta , Edward Franek

Background: Ehlers–Danlos syndrome is a group of genetic conditions characterized by alterations in connective tissue structure, which produces various symptoms. Some subtypes of this syndrome are associated with structural alterations of tenascin-X, an extracellular matrix glycoprotein encoded by the TNXB gene, which partially overlaps the CYP21A2 gene, which encodes adrenal 21-hydroxylase. The purpose of this study was to assess the relationship between tenascin-X level...